BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

134 related articles for article (PubMed ID: 14514146)

  • 1. A prospective study of Chlamydia pneumoniae antibodies in children between 7 months and 8 years of age.
    Volanen I; Vainionpää R; Ilonen J; Markula P; Kallio K; Kaitosaari T; Helenius H; Simell O
    Scand J Infect Dis; 2003; 35(8):471-7. PubMed ID: 14514146
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Prevalence of Chlamydia pneumoniae and Mycoplasma pneumoniae immunoglobulin G and A antibodies in a healthy Finnish population as analyzed by quantitative enzyme immunoassays.
    Tuuminen T; Varjo S; Ingman H; Weber T; Oksi J; Viljanen M
    Clin Diagn Lab Immunol; 2000 Sep; 7(5):734-8. PubMed ID: 10973446
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Prevalence and persistence of Chlamydia pneumoniae antibodies in healthy laboratory personnel in Finland.
    Paldanius M; Bloigu A; Alho M; Leinonen M; Saikku P
    Clin Diagn Lab Immunol; 2005 May; 12(5):654-9. PubMed ID: 15879028
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Antibody responses of Chlamydophila pneumoniae pneumonia: Why is the diagnosis of C. pneumoniae pneumonia difficult?
    Miyashita N; Kawai Y; Tanaka T; Akaike H; Teranishi H; Wakabayashi T; Nakano T; Ouchi K; Okimoto N
    J Infect Chemother; 2015 Jul; 21(7):497-501. PubMed ID: 25840889
    [TBL] [Abstract][Full Text] [Related]  

  • 5. A population based seroepidemiological survey of Chlamydia pneumoniae infections in schoolchildren.
    Dal Molin G; Longo B; Not T; Poli A; Campello C
    J Clin Pathol; 2005 Jun; 58(6):617-20. PubMed ID: 15917413
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Prevalence of antibodies to Chlamydia pneumoniae in an Israeli population without clinical evidence of respiratory infection.
    Ben-Yaakov M; Eshel G; Zaksonski L; Lazarovich Z; Boldur I
    J Clin Pathol; 2002 May; 55(5):355-8. PubMed ID: 11986341
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Seroprevalence of IgG antibodies against Chlamydia pneumoniae in Chinese, Malays and Asian Indians in Singapore.
    Koh WP; Taylor MB; Hughes K; Chew SK; Fong CW; Phoon MC; Kang KL; Chow VT
    Int J Epidemiol; 2002 Oct; 31(5):1001-7. PubMed ID: 12435775
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Serum lipid profiles poorly correlate with Chlamydia pneumoniae, Helicobacter pylori, and cytomegalovirus seropositivity in prospectively followed-up healthy children.
    Volanen I; Raitakari OT; Vainionpää R; Arffman M; Aarnisalo J; Anglé S; Kallio K; Simell O
    Arterioscler Thromb Vasc Biol; 2005 Apr; 25(4):827-32. PubMed ID: 15692096
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Serologic diagnosis of chlamydial and Mycoplasma pneumoniae infections].
    de Barbeyrac B; Obeniche F; Ratsima E; Labrouche S; Moraté C; Renaudin H; Pereyre S; Bébéar CM; Bébéar C
    Ann Biol Clin (Paris); 2006; 64(5):409-19. PubMed ID: 17040871
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Serological study on Chlamydophila pneumoniae in patients with community-acquired pneumonia.
    Ciarrocchi G; De Benedetto F; Fogliani V; Magliano E; Del Prete R; Miragliotta G
    New Microbiol; 2004 Oct; 27(4):335-43. PubMed ID: 15646047
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Prevalence of Mycoplasma pneumoniae and Chlamydia pneumoniae in pneumonia patients in four major hospitals in Trinidad.
    Nagalingam NA; Adesiyun AA; Swanston WH; Bartholomew M
    New Microbiol; 2004 Oct; 27(4):345-51. PubMed ID: 15646048
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Chronic Chlamydia pneumoniae infection and bronchial asthma: is there a link?
    Agarwal A; Chander Y
    Indian J Med Microbiol; 2008; 26(4):338-41. PubMed ID: 18974486
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Antibody levels against Chlamydia pneumoniae and outcome of roxithromycin therapy in patients with acute myocardial infarction. Results from a sub-study of the randomised Antibiotic Therapy in Acute Myocardial Infarction (ANTIBIO) trial.
    Burkhardt U; Zahn R; Höffler U; Siegler KE; Frilling B; Weber M; Gottwik M; Wehr M; Seidel F; Rosocha S; Tebbe U; Senges J
    Z Kardiol; 2004 Sep; 93(9):671-8. PubMed ID: 15365734
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Evaluation of serological tests detecting Chlamydophila pneumoniae-specific immunoglobulin M antibody.
    Miyashita N; Obase Y; Fukuda M; Shoji H; Mouri K; Yagi S; Yoshida K; Ouchi K; Oka M
    Intern Med; 2006; 45(20):1127-31. PubMed ID: 17106155
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Seroprevalence of antibodies to Chlamydia pneumoniae in women with preeclampsia.
    Heine RP; Ness RB; Roberts JM
    Obstet Gynecol; 2003 Feb; 101(2):221-6. PubMed ID: 12576242
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Chlamydia pneumoniae seropositivity is associated with increased plasma levels of soluble cellular adhesion molecules in community-dwelling subjects: the Shimanami Health Promoting Program (J-SHIPP) study.
    Kohara K; Tabara Y; Yamamoto Y; Igase M; Miki T
    Stroke; 2002 Jun; 33(6):1474-9. PubMed ID: 12052977
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Prevalence of chlamydia-pneumoniae-specific immunoglobulin M antibody and acute exacerbations of asthma in childhood].
    Sato S; Kawashima H; Kashiwagi Y; Ushio N; Nagai M; Takekuma K; Hoshika A
    Arerugi; 2007 Nov; 56(11):1378-83. PubMed ID: 18059151
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Assay of specific anti-Chlamydia pneumoniae antibodies by ELISA method. 2. studies on clinical usefulness and serological diagnostic standards].
    Kishimoto T; Kubota Y; Matsushima T; Izutsu H; Matsumoto A; Soejima R; Numazaki K; Chiba S; Yamazaki T; Sasaki N; Kaku M; Shimada J; Iwasaki E; Baba M; Koori Y; Aihara M; Chikumi H; Kosaba S; Nonaka Y; Ouchi K; Yamamoto T; Kashiwagi S; Kawayama T; Ohizumi K; Nagai H
    Kansenshogaku Zasshi; 1996 Aug; 70(8):830-9. PubMed ID: 8890551
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Measurement of Chlamydia pneumoniae-specific immunoglobulin A (IgA) antibodies by the microimmunofluorescence (MIF) method: comparison of seven fluorescein-labeled anti-human IgA conjugates in an in-house MIF test using one commercial MIF and one enzyme immunoassay kit.
    Paldanius M; Bloigu A; Leinonen M; Saikku P
    Clin Diagn Lab Immunol; 2003 Jan; 10(1):8-12. PubMed ID: 12522032
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Evaluation and optimization of a commercial enzyme linked immunosorbent assay for detection of Chlamydophila pneumoniae IgA antibodies.
    Frikha-Gargouri O; Gdoura R; Znazen A; Ben Arab N; Gargouri J; Ben Jemaa M; Hammami A
    BMC Infect Dis; 2008 Jul; 8():98. PubMed ID: 18655722
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.